Where is Larimar Therapeutics headquartered?

Larimar Therapeutics is located in Bala Cynwyd, PA.

Who invested in Larimar Therapeutics?

Larimar Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Larimar Therapeutics raised to date?

Larimar Therapeutics has raised ____.

When was the last funding round for Larimar Therapeutics?

Larimar Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

larimartx.com

Larimar Therapeutics

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address: Three Bala Plaza East

City: Bala Cynwyd

State: PA

Zip: 19004

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$95M

Raised Total:

$250M

Social

Crunchbase

Metrics

3,526,938Website Global Rank

3,960Website Monthly Traffic

Twitter Followers

Description

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Contact Phone:
+18445119056

Contact Email:

IPO Details

Larimar Therapeutics went public on 6/18/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/18/2014

IPO Valuation:
$312M

Ticker Symbol:
LRMR

IPO Price:
$14/share

Amount Raised:
$96M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2010	Series B	2	$28M	Third Rock Ventures Atlas Venture
12/2012	Series D	3	$21M	Alta Partners Third Rock Ventures Atlas Venture Alta Partners
9/2022	Post-IPO Equity	1	$70M	Deerfield Management Deerfield Management
9/2006	Series A	1	$5.2M	Atlas Venture Atlas Venture
8/2012	Debt Financing		$3M
12/2013	Series E	4	$45M	Venrock RA Capital Management Brookside Capital Alta Partners Venrock
4/2014	Debt Financing	2	$20M	Oxford Finance LLC MidCap Financial Oxford Finance LLC MidCap Financial
5/2021	Post-IPO Equity		$0	Adage Capital Management Cowen Healthcare Investments Deerfield RA Capital Management Surveyor Capital Verition Fund Management Vivo Capital Adage Capital Management Cowen Healthcare Investments Deerfield RA Capital Management Surveyor Capital Verition Fund Management Vivo Capital
7/2011	Series C	2	$33M	Atlas Venture Third Rock Ventures Atlas Venture Third Rock Ventures
5/2021	Post-IPO Equity	7	$95M	Adage Capital Management Cowen Healthcare Investments Deerfield RA Capital Management Surveyor Capital Verition Fund Management Vivo Capital Adage Capital Management Cowen Healthcare Investments Deerfield RA Capital Management Surveyor Capital Verition Fund Management Vivo Capital

Acquisitions

Announced Date	Name	Price
12/2019	Chondrial Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details